Motixafortide acetate - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for motixafortide acetate and what is the scope of patent protection?
Motixafortide acetate
is the generic ingredient in one branded drug marketed by Biolinerx Ltd and is included in one NDA. Additional information is available in the individual branded drug profile pages.One supplier is listed for this compound.
Summary for motixafortide acetate
US Patents: | 0 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
DailyMed Link: | motixafortide acetate at DailyMed |
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for motixafortide acetate
Generic Entry Date for motixafortide acetate*:
Constraining patent/regulatory exclusivity:
TO MOBILIZE HEMATOPOIETIC STEM CELLS TO THE PERIPHERAL BLOOD FOR COLLECTION AND SUBSEQUENT AUTOLOGOUS TRANSPLANTATION IN PATIENTS WITH MULTIPLE MYELOMA Dosage:
POWDER;SUBCUTANEOUS |
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
US Patents and Regulatory Information for motixafortide acetate
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Biolinerx Ltd | APHEXDA | motixafortide acetate | POWDER;SUBCUTANEOUS | 217159-001 | Sep 8, 2023 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Biolinerx Ltd | APHEXDA | motixafortide acetate | POWDER;SUBCUTANEOUS | 217159-001 | Sep 8, 2023 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |